Processa Pharmaceuticals, Inc. (PCSA) Insider Trading Activity

NASDAQ$1.95+0.01 (0.52%)
Market Cap
$5.43M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
231 of 849
Rank in Industry
134 of 491

PCSA Insider Trading Activity

PCSA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$203,165
41
100
Sells
$0
0
0

Related Transactions

SKIBSTED RUSSELLChief Financial Officer
7
$41,674
0
$0
$41,674
Ng George KChief Executive Officer
7
$38,677
0
$0
$38,677
Guy WendyChief Administrative Officer
7
$32,909
0
$0
$32,909
Young DavidPres. Research & Development
7
$32,418
0
$0
$32,418
Lin PatrickChief Business - Strategy Off
7
$28,455
0
$0
$28,455
Bigora SianChief Development Officer
3
$16,026
0
$0
$16,026
Baluch Khosodirector
1
$5,752
0
$0
$5,752
Pannu Geraldinedirector
1
$5,253
0
$0
$5,253
Neal James Rdirector
1
$2,000
0
$0
$2,000

About Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States. The company's leading investigational drug, PCS499, is an oral tablet presently undergoing Phase 2B clinical assessment. It aims to treat both ulcerative and non-ulcerative manifestations of necrobiosis lipoidica, a chronic and disfiguring dermatological condition. Processa's portfolio also features …

Insider Activity of Processa Pharmaceuticals, Inc.

Over the last 12 months, insiders at Processa Pharmaceuticals, Inc. have bought $203,165 and sold $0 worth of Processa Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Processa Pharmaceuticals, Inc. have bought $137,449 and sold $52,501 worth of stock each year.

Highest buying activity among insiders over the last 12 months: SKIBSTED RUSSELL (Chief Financial Officer) — $41,674. Ng George K (Chief Executive Officer) — $38,677. Guy Wendy (Chief Administrative Officer) — $32,909.

The last purchase of 3,057 shares for transaction amount of $5,900 was made by Ng George K (Chief Executive Officer) on 2026‑07‑01.

List of Insider Buy and Sell Transactions, Processa Pharmaceuticals, Inc.

2026-07-01PurchaseNg George KChief Executive Officer
3,057
0.1356%
$1.93
$5,900
+4.08%
2026-06-30PurchaseYoung DavidPres. Research & Development
2,531
0.1123%
$1.93
$4,885
+5.99%
2026-06-30PurchaseSKIBSTED RUSSELLChief Financial Officer
3,277
0.1454%
$1.93
$6,325
+5.99%
2026-06-30PurchaseGuy WendyChief Administrative Officer
2,436
0.1081%
$1.93
$4,701
+5.99%
2026-06-30PurchaseLin PatrickChief Business - Strategy Off
2,106
0.0934%
$1.93
$4,065
+5.99%
2026-06-15PurchaseYoung DavidPres. Research & Development
2,067
0.0916%
$2.22
$4,589
-8.37%
2026-06-15PurchaseSKIBSTED RUSSELLChief Financial Officer
2,654
0.1177%
$2.22
$5,892
-8.37%
2026-06-15PurchaseNg George KChief Executive Officer
2,465
0.1093%
$2.22
$5,472
-8.37%
2026-06-15PurchaseGuy WendyChief Administrative Officer
2,118
0.0939%
$2.22
$4,702
-8.37%
2026-06-15PurchaseLin PatrickChief Business - Strategy Off
1,831
0.0812%
$2.22
$4,065
-8.37%
2026-05-29PurchaseYoung DavidPres. Research & Development
1,786
0.0791%
$2.57
$4,590
-19.92%
2026-05-29PurchaseSKIBSTED RUSSELLChief Financial Officer
2,292
0.1016%
$2.57
$5,890
-19.92%
2026-05-29PurchaseNg George KChief Executive Officer
2,129
0.0943%
$2.57
$5,472
-19.92%
2026-05-29PurchaseGuy WendyChief Administrative Officer
1,829
0.081%
$2.57
$4,701
-19.92%
2026-05-29PurchaseLin PatrickChief Business - Strategy Off
1,582
0.0701%
$2.57
$4,066
-19.92%
2026-05-15PurchaseYoung DavidPres. Research & Development
1,545
0.0684%
$2.97
$4,589
-30.07%
2026-05-15PurchaseSKIBSTED RUSSELLChief Financial Officer
1,984
0.0879%
$2.97
$5,892
-30.07%
2026-05-15PurchaseGuy WendyChief Administrative Officer
1,583
0.0701%
$2.97
$4,702
-30.07%
2026-05-15PurchaseNg George KChief Executive Officer
1,843
0.0816%
$2.97
$5,474
-30.07%
2026-05-15PurchaseLin PatrickChief Business - Strategy Off
1,369
0.0606%
$2.97
$4,066
-30.07%
Total: 79
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Young DavidPres. Research & Development
21729
0.7765%
$42,154.26160
<0.0001%
SKIBSTED RUSSELLChief Financial Officer
16689
0.5964%
$32,376.6670
Ng George KChief Executive Officer
15492
0.5536%
$30,054.4890
<0.0001%
Guy WendyChief Administrative Officer
14394
0.5144%
$27,924.3670
Lin PatrickChief Business - Strategy Off
13113
0.4686%
$25,439.22170
<0.0001%
Bigora SianChief Development Officer
7481
0.2673%
$14,513.1430
Baluch Khosodirector
2325
0.0831%
$4,510.5010
Pannu Geraldinedirector
2188
0.0782%
$4,244.7210
Neal James Rdirector
818
0.0292%
$1,586.9210
BESSER JAMES E
648300
23.1681%
$1.26M16
Stanker James HChief Financial Officer
36510
1.3047%
$70,829.4020
Floyd Robert MichaelChief Operating Officer
28000
1.0006%
$54,320.0010
Yorke Justin Wdirector
12400
0.4431%
$24,056.0025
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$6,974,678
45
-14.98%
$4.63M
$13,664,154
40
-70.35%
$7.05M
$29,645,465
28
8.09%
$6.48M
$63,749,694
24
-12.24%
$6.4M
$287,718
15
-41.45%
$5.68M

PCSA Institutional Investors: Active Positions

Increased Positions7+36.84%79,067+108.44%
Decreased Positions9-47.37%36,803-50.48%
New Positions3New62,521New
Sold Out Positions7Sold Out7,917Sold Out
Total Postitions17-10.53%115,174+57.97%

PCSA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Stonepine Capital Management, Llc$121.002.06%41,208+41,208New2025-09-30
Geode Capital Management, Llc$36.000.61%12,132+10,109+499.7%2025-09-30
Vanguard Group Inc$34.000.58%11,528+10,551+1,079.94%2025-09-30
Virtu Financial Llc$5.000.08%1,634-2,555-60.99%2025-09-30
Two Sigma Securities, Llc$4.000.07%1,450+1,450New2025-09-30
Citigroup Inc$4.000.07%1,362+1,362New2025-09-30
Stonex Group Inc.$2.000.04%758+758New2025-09-30
Sassicaia Capital Advisers Llc$2.000.03%639+639New2025-09-30
Miracle Mile Advisors, Llc$1.000.02%400+400New2025-09-30
Tower Research Capital Llc (Trc)$00.01%96-2-2.04%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.